Bulk Manufacturer of Controlled Substances Application: National Center for Natural Products Research NIDA MPROJECT, 44672-44673 [2018-18983]
Download as PDF
44672
Federal Register / Vol. 83, No. 170 / Friday, August 31, 2018 / Notices
complaint can be accessed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov, and will be
available for inspection during official
business hours (8:45 a.m. to 5:15 p.m.)
in the Office of the Secretary, U.S.
International Trade Commission, 500 E
Street SW, Washington, DC 20436,
telephone (202) 205–2000.
General information concerning the
Commission may also be obtained by
accessing its internet server (https://
www.usitc.gov). The public record for
this investigation may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov. Hearingimpaired persons are advised that
information on this matter can be
obtained by contacting the
Commission’s TDD terminal on (202)
205–1810.
SUPPLEMENTARY INFORMATION: Section
337 of the Tariff Act of 1930 provides
that if the Commission finds a violation
it shall exclude the articles concerned
from the United States:
daltland on DSKBBV9HB2PROD with NOTICES
unless, after considering the effect of such
exclusion upon the public health and
welfare, competitive conditions in the United
States economy, the production of like or
directly competitive articles in the United
States, and United States consumers, it finds
that such articles should not be excluded
from entry.
19 U.S.C. 1337(d)(1). A similar
provision applies to cease and desist
orders. 19 U.S.C. 1337(f)(1).
The Commission is interested in
further development of the record on
the public interest in these
investigations. Accordingly, parties are
to file public interest submissions
pursuant to pursuant to 19 CFR
210.50(a)(4). In addition, members of
the public are hereby invited to file
submissions of no more than five (5)
pages, inclusive of attachments,
concerning the public interest in light of
the administrative law judge’s
Recommended Determination on
Remedy and Bonding issued in this
investigation on July 23, 2018.
Comments should address whether
issuance of a limited exclusion order
and cease and desist orders in this
investigation directed to respondents’
LiSi Press products would affect the
public health and welfare in the United
States, competitive conditions in the
United States economy, the production
of like or directly competitive articles in
the United States, or United States
consumers.
In particular, the Commission is
interested in comments that:
(i) Explain how the articles
potentially subject to the recommended
orders are used in the United States;
VerDate Sep<11>2014
18:42 Aug 30, 2018
Jkt 244001
(ii) identify any public health, safety,
or welfare concerns in the United States
relating to the recommended orders;
(iii) identify like or directly
competitive articles that complainant,
its licensees, or third parties make in the
United States which could replace the
subject articles if they were to be
excluded;
(iv) indicate whether complainant,
complainant’s licensees, and/or third
party suppliers have the capacity to
replace the volume of articles
potentially subject to the recommended
exclusion order and/or a cease and
desist order within a commercially
reasonable time; and
(v) explain how the limited exclusion
order and cease and desist orders would
impact consumers in the United States.
Written submissions from the public
must be filed no later than by close of
business on September 13, 2018.
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above and submit 8 true paper
copies to the Office of the Secretary by
noon the next day pursuant to section
210.4(f) of the Commission’s Rules of
Practice and Procedure (19 CFR
210.4(f)). Submissions should refer to
the investigation number (‘‘Inv. No.
337–TA–1050’’) in a prominent place on
the cover page and/or the first page. (See
Handbook for Electronic Filing
Procedures, https://www.usitc.gov/
secretary/documents/handbook_on_
filing_procedures.pdf.) Persons with
questions regarding filing should
contact the Secretary (202–205–2000).
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. A redacted nonconfidential version of the document
must also be filed simultaneously with
any confidential filing. All nonconfidential written submissions will be
available for public inspection at the
Office of the Secretary and on EDIS.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in Part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
PO 00000
Frm 00111
Fmt 4703
Sfmt 4703
Issued: August 27, 2018.
Katherine Hiner,
Supervisory Attorney.
[FR Doc. 2018–18886 Filed 8–30–18; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: National
Center for Natural Products Research
NIDA MPROJECT
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 30, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division pursuant to section 7
of 28 CFR part 0, appendix to subpart
R.
In accordance with 21 CFR
1301.33(a), this is notice that on July 6,
2018, National Center for Natural
Products Research NIDA MPROJECT,
University of Mississippi, 135 Coy
Waller Complex, P.O. Box 1848,
University, Mississippi 38677–1848
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
DATES:
Controlled substance
Marihuana Extract ......
Marihuana ..................
Tetrahydrocannabinols
E:\FR\FM\31AUN1.SGM
31AUN1
Drug
code
7350
7360
7370
Schedule
I
I
I
Federal Register / Vol. 83, No. 170 / Friday, August 31, 2018 / Notices
The company plans to bulk
manufacture the listed controlled
substances to make available to the
National Institute on Drug Abuse
(NIDA) a supply of bulk marihuana for
distribution to research investigators in
support of the national research
program needs. No other activities for
these drug codes are authorized for this
registration.
Dated: August 22, 2018.
John J. Martin,
Assistant Administrator.
DEPARTMENT OF JUSTICE
Corrected Notice of Lodging Proposed
Consent Decree
daltland on DSKBBV9HB2PROD with NOTICES
[FR Doc. 2018–18871 Filed 8–30–18; 8:45 am]
BILLING CODE 4410–15–P
Wage and Hour Division
BILLING CODE 4410–09–P
In accordance with Departmental
Policy, 28 CFR 50.7, notice is hereby
given that a proposed Consent Decree in
United States v. Richard M. Osborne,
Sr., et al., Case No. 1:11–cv–2039–CAB,
was lodged with the United States
District Court for the Northern District
of Ohio on August 10, 2018.
This proposed Consent Decree
concerns a complaint filed by the
United States against Defendants
Richard M. Osborne, Sr., Great Plains
Exploration, LLC, Center Street
Investments, Inc., Callendar Real Estate
Development Company, LLC, and Osair,
Inc., pursuant to Sections 301(a), 309(b),
and 309(d) of the Clean Water Act, 33
U.S.C. 1311(a), 1319(b), and 1319(d), to
obtain injunctive relief from and impose
civil penalties against the Defendants
for violating the Clean Water Act by
discharging pollutants without a permit
into waters of the United States. The
proposed Consent Decree resolves these
allegations by requiring the Defendants
to mitigate for the harms caused by the
impacted areas.
The Department of Justice will accept
written comments relating to this
proposed Consent Decree for thirty (30)
days from the date of publication of this
Corrected Notice. Please address
comments to Phillip R. Dupre´, United
State Department of Justice,
Environment and Natural Resources
Division, Post Office Box 7611,
Washington, DC 20044–7611 and refer
to United States v. Richard M. Osborne,
Sr., et al., Case No. 1:11–cv–2039–CAB,
DJ #90–5–1–1–18628.
The proposed Consent Decree may be
examined at the Clerk’s Office, United
States District Court for the Northern
District of Ohio, Carl B. Stokes United
States Courthouse, 801 West Superior
Avenue, Cleveland, OH 44113. In
addition, the proposed Consent Decree
18:42 Aug 30, 2018
Cherie L. Rogers,
Assistant Section Chief, Environmental
Defense Section, Environment and Natural
Resources Division.
DEPARTMENT OF LABOR
[FR Doc. 2018–18983 Filed 8–30–18; 8:45 am]
VerDate Sep<11>2014
may be examined electronically at
https://www.justice.gov/enrd/Consent_
Decrees.html.
Jkt 244001
Agency Information Collection
Activities; Comment Request;
Information Collections: Work Study
Program of the Child Labor
Regulations
Wage and Hour Division,
Department of Labor,
ACTION: Notice.
AGENCY:
The Department of Labor
(DOL) is soliciting comments
concerning a proposed extension to the
information collection request (ICR)
titled, ‘‘Work-Study Program of the
Child Labor Regulations.’’ This
comment request is part of continuing
Departmental efforts to reduce
paperwork and respondent burden in
accordance with the Paperwork
Reduction Act of 1995 (PRA), 44 U.S.C.
3501 et seq.
This program helps to ensure that
requested data can be provided in the
desired format, reporting burden (time
and financial resources) is minimized,
collection instruments are clearly
understood, and the impact of collection
requirements on respondents can be
properly assessed. A copy of the
proposed information request can be
obtained by contacting the office listed
below in the FOR FURTHER INFORMATION
CONTACT section of this Notice.
DATES: Written comments must be
submitted to the office listed in the
ADDRESSES section below on or before
October 30, 2018.
ADDRESSES: You may submit comments
identified by Control Number 1235–
0024, by either one of the following
methods: Email: WHDPRAComments@
dol.gov; Mail, Hand Delivery, Courier:
Division of Regulations, Legislation, and
Interpretation, Wage and Hour, U.S.
Department of Labor, Room S–3502, 200
Constitution Avenue NW, Washington,
DC 20210. Instructions: Please submit
one copy of your comments by only one
method. All submissions received must
include the agency name and Control
Number identified above for this
information collection. Because we
SUMMARY:
PO 00000
Frm 00112
Fmt 4703
Sfmt 4703
44673
continue to experience delays in
receiving mail in the Washington, DC
area, commenters are strongly
encouraged to transmit their comments
electronically via email or to submit
them by mail early. Comments,
including any personal information
provided, become a matter of public
record. They will also be summarized
and/or included in the request for Office
of Management and Budget (OMB)
approval of the information collection
request.
FOR FURTHER INFORMATION CONTACT:
Robert Waterman, Compliance
Specialist, Division of Regulations,
Legislation, and Interpretation, Wage
and Hour Division, U.S. Department of
Labor, Room S–3502, 200 Constitution
Avenue NW, Washington, DC 20210;
telephone: (202) 693–0406 (this is not a
toll-free number). Copies of this notice
may be obtained in alternative formats
(Large Print, Braille, Audio Tape, or
Disc), upon request, by calling (202)
693–0023 (not a toll-free number). TTY/
TTD callers may dial toll-free (877) 889–
5627 to obtain information or request
materials in alternative formats.
SUPPLEMENTARY INFORMATION:
I. Background: The Wage and Hour
Division (WHD) of the Department of
Labor administers the Fair Labor
Standards Act (FLSA). Section 3(l) of
the Act establishes a minimum age of 16
years for most nonagricultural
employment, but allows the
employment of 14- and 15-year olds in
occupations other than manufacturing
and mining if the Secretary of Labor
determines such employment is
confined to: (1) Periods that will not
interfere with the minor’s schooling;
and (2) conditions that will not interfere
with the minor’s health and well-being.
FLSA section 11(c) requires all covered
employers to make, keep, and preserve
records of their employees’ wages,
hours, and other conditions and
practices of employment. Section 11(c)
authorizes the Secretary of Labor to
prescribe the recordkeeping and
reporting requirements for these
records. The regulations set forth
reporting requirements that include a
Work Study Program application and
written participation agreement. In
order to utilize the child labor work
study provisions, § 570.35(b) requires a
local public or private school system to
file with the Wage and Hour Division
Administrator an application for
approval of a Work Study Program as
one that does not interfere with the
schooling or health and well-being of
the minors involved. The regulations
also require preparation of a written
participation agreement for each student
E:\FR\FM\31AUN1.SGM
31AUN1
Agencies
[Federal Register Volume 83, Number 170 (Friday, August 31, 2018)]
[Notices]
[Pages 44672-44673]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-18983]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: National
Center for Natural Products Research NIDA MPROJECT
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before October 30, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
pursuant to section 7 of 28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on July
6, 2018, National Center for Natural Products Research NIDA MPROJECT,
University of Mississippi, 135 Coy Waller Complex, P.O. Box 1848,
University, Mississippi 38677-1848 applied to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Marihuana Extract................. 7350............. I
Marihuana......................... 7360............. I
Tetrahydrocannabinols............. 7370............. I
------------------------------------------------------------------------
[[Page 44673]]
The company plans to bulk manufacture the listed controlled
substances to make available to the National Institute on Drug Abuse
(NIDA) a supply of bulk marihuana for distribution to research
investigators in support of the national research program needs. No
other activities for these drug codes are authorized for this
registration.
Dated: August 22, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-18983 Filed 8-30-18; 8:45 am]
BILLING CODE 4410-09-P